Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)
Close on Nov 17, 2026Market cap $148.68MP/E –Yield –
Abeona Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Abeona Therapeutics's pe ratio was 6.5× on Jul 31, 2026, against 7.7× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 6.5× | +3.1 |
| 2025 | Dec 31, 2025 | 3.4× | −4.4 |
| 2014 | Apr 30, 2014 | 7.7× | +7.5 |
| 2013 | Dec 31, 2013 | 0.3× | – |
See a number that looks wrong?